Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors
Hematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced t…
NeuroblastomaRhabdomyosarcomaSynovial Sarcoma+11 more
Estimated
~$10 – $6,250
University of FloridaNCT06625190
Phase 2
Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
To find out if ubamatamab, given by itself or in combination with cemiplimab, can help to control the disease in participants with renal medullary carcinoma (R…
SMARCB1-Deficient MalignanciesEpithelioid SarcomaRenal Medullary Carcinoma
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT06444880
Phase 1
A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of HH2853 in Patients With Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors
This is an open-label, multicenter, first-in-human phase I/II study which is composed of 3 parts: phase I dose escalation, phase I dose extension and phase II.…
FL LymphomaEpithelioid SarcomaPeripheral T Cell Lymphoma+1 more
Estimated
~$10 – $8,750
Haihe Biopharma Co., Ltd.NCT04390737